Alembic Pharmaceuticals gets USFDA nod for generic migraine treatment injection
Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic version of Sumatriptan injection used in treatment of migraine. The approval by the US Food & Drug Administration (USFDA) is for the Abbreviated New Drug Application (ANDA) Sumatriptan Injection of strengths 4 mg/0.5 ml and 6…